Be the Bridge Between Researchers and a Cure (GVHD, ALS, Hepatitis B, Alzheimer's Disease, Leukemia, and More)

This study is currently recruiting participants. (see Contacts and Locations)
Verified June 2014 by Sanguine Biosciences
Sponsor:
Information provided by (Responsible Party):
Sanguine Biosciences
ClinicalTrials.gov Identifier:
NCT01931644
First received: August 23, 2013
Last updated: June 10, 2014
Last verified: June 2014
  Purpose

At Sanguine, we consider ourselves the bridge between patients and researchers striving to find new treatments and diagnostics for numerous medical conditions. We collect biospecimens like blood for medical researchers. Donate from your home, track your sample, and help advance medical research.


Condition
All Diagnosed Health Conditions

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Cross-Sectional
Official Title: A Multi-Site Tissue Repository Providing Annotated Biospecimens for Approved Investigator-Directed Biomedical Research Initiatives

Resource links provided by NLM:


Further study details as provided by Sanguine Biosciences:

Primary Outcome Measures:
  • Biospecimen & Clinical Data Collection [ Time Frame: 10 years ] [ Designated as safety issue: No ]
    To collect enough biospecimens and associated clinical data to allow researchers to come to statistically relevant scientific results


Biospecimen Retention:   Samples With DNA

Whole blood, serum, plasma, PBMC, RNA, DNA, saliva, stool, hair, skin, CSF, synovial fuid, tumor tissue, urine


Estimated Enrollment: 20000
Study Start Date: July 2013
Estimated Study Completion Date: December 2040
Estimated Primary Completion Date: August 2020 (Final data collection date for primary outcome measure)
Groups/Cohorts
Health Condition
Collect blood and other optional biospecimens from participants with a diagnosed health condition
Healthy Control
Collect blood and other optional biospecimens from participants that have not been diagnosed with a health condition

Detailed Description:

This study will collect blood and other optionally donated tissue samples from people with all different types of health conditions, as well as healthy control samples, in order to provide biomedical researchers with quality biospecimens that are necessary in translating basic science research into clinically relevant information and technology.

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Sampling Method:   Probability Sample
Study Population

Diagnosed with a health condition

Criteria

Inclusion Criteria:

  • All adults 18-100 years old
  • Able to provide proof of diagnosis
  • Live in USA

Exclusion Criteria:

  • Younger than 18 years old
  • Receipt of blood products within 30 days of study blood collection
  • Receipt of investigational drug within 30 days of study blood collection
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01931644

Contacts
Contact: Carlyn Crisostomo, MBA 877-864-3053 donors@sanguinebio.com
Contact: Kristen Warren, MBS 877-864-3053 study@sanguinebio.com

Locations
United States, California
Sanguine Biosciences Recruiting
Los Angeles, California, United States, 91403
Contact: Carlyn Crisostomo    877-864-3053    donors@sanguinebio.com   
Contact: Kristen Warren, MBS    877-864-3053    study@sanguinebio.com   
Principal Investigator: Carlyn Crisostomo         
Sub-Investigator: Kristen Warren, MBS         
Sponsors and Collaborators
Sanguine Biosciences
Investigators
Principal Investigator: Carlyn Crisostomo Sanguine Biosciences
  More Information

No publications provided

Responsible Party: Sanguine Biosciences
ClinicalTrials.gov Identifier: NCT01931644     History of Changes
Other Study ID Numbers: SAN-BB-01
Study First Received: August 23, 2013
Last Updated: June 10, 2014
Health Authority: United States: Institutional Review Board

Keywords provided by Sanguine Biosciences:
Graft-versus-Host Disease (GVHD)
Amyotrophic Lateral Sclerosis (ALS)
Cancer
Diabetes
Melanoma
Hepatitis B
Lupus
Multiple Sclerosis
Asthma
Crohn's Disease
Ulcerative Colitis
Kidney Disease
Alzheimer's Disease
Parkinson's Disease
Huntington's Disease
Rheumatoid Arthritis
Sjogren's Syndrome
Leukemia
Lymphoma
Myeloma
CIDP
COPD
Idiopathic Thrombocytopenia Purpura
Cystic Fibrosis
Primary Biliary Cirrhosis

Additional relevant MeSH terms:
Alzheimer Disease
Brain Diseases
Central Nervous System Diseases
Delirium, Dementia, Amnestic, Cognitive Disorders
Dementia
Mental Disorders
Nervous System Diseases
Neurodegenerative Diseases
Tauopathies

ClinicalTrials.gov processed this record on October 23, 2014